What are you searching for…

Fact or Fiction

25-10-2020

Fact or Fiction

In 2020, approximately 276,480 new cases of invasive breast cancer were expected to be diagnosed in women in the U.S. Take a look at the Baker Ruskinn database to learn more about the hundreds of Cancer Researchers we have worked with in multiple countries across the world. 

View the publications here

Day 1 of Analytica Virtual 2020!

19-10-2020

Day 1 of Analytica Virtual 2020!

Join us at Analytica Virtual! Learn more about Baker Ruskinn's Physiological Cell Culture Workstations and CleanAir by Baker's Biological Safety Cabinets.

Visit The Baker Company's booth if you're already registered or sign up today (free of charge). #Analytica2020

Novel Nasal Spray

17-10-2020

Novel Nasal Spray

A new nasal spray, INNA-051, produced by Ena Respiratory could reach human trials within four months. Researchers have revealed that the nasal spray significantly reduced COVID-19 virus replication levels by up to 96%. 

Find out more for yourself

Investigational mRNA Vaccine

13-10-2020

Investigational mRNA Vaccine

Phase 1 of a trial into an investigational mRNA vaccine, developed by researchers at NIAID and Moderna is underway. The vaccine is to prevent SARS-CoV-2 infection and has shown to have a strong immune response in older adults.

Read more here

Neutralizing Antibodies

12-10-2020

Neutralizing Antibodies

Two leading clinical organizations have recently identified neutralizing antibodies with great potential. It has been anticipated that monoclonal antibodies will play a vital role in the fight against COVID-19. 

Find out more for yourself

A Controlled Atmosphere with Superior Performance

10-10-2020

A Controlled Atmosphere with Superior Performance

Looking for a fully controlled atmosphere with superior performance? Rather than constructing an expensive cleanroom, speak to us about Physiological Oxygen ISO Class 3 workstations from Baker Ruskinn.

Find out more

Investigational Drugs

09-10-2020

Investigational Drugs

Two novel and investigational drugs supported by the U.S Department of Health has moved into the advanced stages of development. The innovative drugs are currently used to treat antibiotic resistant infections and therefore have the potential to also treat COVID-19. 

Read more here

Mitigate the Risk of Contamination with CondoCell<sup>®</sup>

04-10-2020

Mitigate the Risk of Contamination with CondoCell®

Mitigate the risk of cross contamination between cultures and from room air particulates with CondoCell®!

Filtered, protected and contained environment for your cells, find out more.

Dr. Ox Update

01-10-2020

Dr. Ox Update

Another weekly round up from Baker’s Director of Scientific Applications, Dr. Ox.

Make sure you’re following Dr. Ox on YouTube and be the first to watch the new interview series launching soon!

Fact or Fiction

30-09-2020

Fact or Fiction

With a new ‘economical’ building and fitted solar panels, at Baker we have reduced our total generation throughout August 2020 to a total of 197 megawatt hours. Together, Baker’s carbon offset equates to 139,000kg of CO2, the equivalent of planting 2,310 trees! Learn more about Baker.

Did you know?

30-09-2020

Did you know?

Through a philosophy anchored in Operation Excellence, Baker strive to design products that improve products, processes and people.

Ask us a question? Get in touch

Contact Us